Public verdict · Technology · NYSE

HubSpot, Inc. (HUBS)

Monsaic grades HubSpot, Inc. (HUBS) BUY, medium conviction, as of 2026-07-07. HubSpot is a high-gross-margin, cash-generative CRM/application-software compounder now priced as if AI materially compresses seat-based SaaS value. The setup is attractive after the drawdown, but the burden of proof has shifted to Q2/Q3 execution, net retention stability, and credible AI-agent monetization.

BUYMedium conviction
Analysis as of · last full analysis
1 of 5 thesis-breakers shown · 10 claim-level citations · 4 valuation scenarios with probabilities · 15 sections — in the full report.

The one risk that matters

EPS power falls toward ~$11.50 and the multiple compresses to ~14x as software budgets, seat growth, and competitive pricing pressure weigh on the model.

Monsaic would change its verdict if

Net revenue retention falls below 100% or management stops disclosing enough retention/customer metrics to assess quality.

One of 5 kill criteria stated before the verdict was graded.

Last full analysis: . This page is a free excerpt and shows no market data; the full report states the price its analysis was built on and when it was observed.

This is the free excerpt of a 15-section Monsaic.

The full Monsaic carries the scenario math, the investigative grades, all 5 kill criteria, and every sourced claim behind this verdict — regenerated on demand.

Get the full Monsaic on HUBS

What the full report covers

  1. 01Executive summary
  2. 02Fundamental analysis
  3. 03Balance sheet analysis
  4. 04Catalyst analysis
  5. 05Valuation & scenarios
  6. 06Comparative precedents
  7. 07Asymmetric risk profile
  8. 08Risk assessment
  9. 09Technical analysis
  10. 10Insider & institutional signals
  11. 11News sentiment
  12. 12Management & governance
  13. 13Narrative vs. substance
  14. 14Dilution & shareholder value
  15. 15Revenue quality

FAQ

Should I buy HUBS stock?

Monsaic’s research verdict on HubSpot, Inc. (HUBS) is BUY with medium conviction, as of 2026-07-07. Whether you should buy depends on your own goals, horizon, and risk tolerance — this is educational research, not personalized investment advice.

What is Monsaic’s verdict on HUBS?

Monsaic grades HubSpot, Inc. (HUBS) BUY, medium conviction, as of 2026-07-07. The verdict comes from a fifteen-section analysis with 5 stated thesis-breakers and 10 claim-level citations, and it is educational research, not personalized investment advice.

When was HubSpot, Inc. last analyzed by Monsaic?

The most recent full Monsaic analysis of HubSpot, Inc. (HUBS) was produced on July 7, 2026. Every report states its analysis date, and a fresh report can be generated on demand.

What would change Monsaic’s verdict on HUBS?

Net revenue retention falls below 100% or management stops disclosing enough retention/customer metrics to assess quality. This is the first of 5 kill criteria the analysis states in advance — the checkable conditions under which the thesis would be considered broken.

What is the key risk for HubSpot, Inc.?

EPS power falls toward ~$11.50 and the multiple compresses to ~14x as software budgets, seat growth, and competitive pricing pressure weigh on the model.

Keep reading

Monsaic provides educational investment research and analysis. It does not provide personalized financial advice, investment recommendations, brokerage services, or trading execution. Investors should do their own research and consult a qualified financial advisor before making investment decisions.